Cancer | Cases (rate per 100 000 person-years) | Crude HR | Adjusted HR (95% CI)* |
---|---|---|---|
Leukaemias | |||
Unexposed | 2522 (4.06) | 1.0 (ref) | 1.0 (ref) |
All exposed | 360 (3.70) | 1.2 | 1.12 (1.00 to 1.26) |
Hodgkin's lymphoma | |||
Unexposed | 123 (0.20) | 1.0 (ref) | 1.0 (ref) |
All exposed | 43 (0.44) | 1.29 | 1.17 (0.81 to 1.67) |
Non-Hodgkin's lymphoma | |||
Unexposed | 441 (0.71) | 1.0 (ref) | 1.0 (ref) |
All Exposed | 68 (0.70) | 1.03 | 0.99 (0.76 to 1.29) |
CNS tumours | |||
Unexposed | 2160 (3.48) | 1.0 (ref) | 1.0 (ref) |
All exposed | 386 (3.97) | 1.19 | 1.14 (1.02 to 1.28) |
Wilms’ tumour† | |||
Unexposed | 564 (0.91) | 1.0 (ref) | 1.0 (ref) |
All exposed | 42 (0.43) | 0.98 | 0.93 (0.68 to 1.28) |
Testicular cancer | |||
Unexposed | 50 (0.08) | 1.0 (ref) | 1.0 (ref) |
All exposed | 5 (0.05) | 1.16 | 1.08 (0.41 to 2.88) |
*Adjusted for country, maternal characteristics at birth (maternal age and parity) and whether child was a twin.
†Proportional hazards assumption not met by model for this cancer subtype.